SB
IRWD icon

Suntrust Banks’s Ironwood Pharmaceuticals IRWD Stock Holding History

Suntrust Banks’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-42,428
Closed -$437K – 1541
2014
Q1 		$437K Buy
42,428
+627
+1% +$7.05K ﹤0.01% 1399
2013
Q4 		$405K Sell
41,801
-2,303
-5% -$20.7K ﹤0.01% 1365
2013
Q3 		$436K Sell
44,104
-392
-0.9% -$3.85K ﹤0.01% 1296
2013
Q2 		$369K Buy
+44,496
New +$539K ﹤0.01% 1319

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Suntrust Banks's IRWD Position: Q2 2014 in Review

Suntrust Banks sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2014, closing a stake of 42,428 shares — an estimated $437K sold.

Suntrust Banks first reported a position in IRWD in Q2 2013 and held it in 4 quarters. The position peaked at $437K in Q1 2014. 138 funds tracked by Wall St. Rank hold IRWD as of Q2 2014.

  • Suntrust Banks reported no remaining Ironwood Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Suntrust Banks sold 42,428 Ironwood Pharmaceuticals shares in Q2 2014, an estimated $437K.
  • Suntrust Banks first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Suntrust Banks's Ironwood Pharmaceuticals position peaked at $437K in Q1 2014.
  • 138 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2014.

Based on Suntrust Banks's 13F filing for Q2 2014, filed 14 Aug 2014.